NCT00205738View on ClinicalTrials.gov

Janssen - Glucose Regulation/Risp/Olanz

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
SchizophreniaType 2 Diabetes Mellitus
Interventions
DRUG

Risperidone, Olanzapine

Trial Locations (1)

63110

Washington University School of Medicine, Psychiatry Dept., St Louis

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT00205738 - Janssen - Glucose Regulation/Risp/Olanz | Biotech Hunter | Biotech Hunter